Exercise on Expression of Heat Shock Protein 70 in Arterial Risk
HSP70
Impact of Exercise on Expression of Hsp70 in Individuals at Risk of Peripheral Arterial Disease. A Randomised Trial
1 other identifier
interventional
32
1 country
1
Brief Summary
Introduction: Atherosclerotic Peripheral Arterial Disease (PAD) is the leading cause of mortality in the western world. To maintain homeostasis of the vessel wall, vascular cells produce a high level of heat shock proteins (HSP), among which is Hsp70, to stimulate innate immunity and face stress. Methods: This is a clinical trial where 260 individuals were evaluated by a screening test employing the Ankle-Arm Index (ABI), 220 of them were not within risk value (0.91 to 0.99 mmHg). In the clinical trial, 32 individuals were included. A control group and an experimental group were formed. Aerobic exercise intervention was performed for 12 weeks. The level of Hsp70 was evaluated, physical and clinical measurements were applied at the beginning and at the end of the trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2019
CompletedFirst Submitted
Initial submission to the registry
January 27, 2021
CompletedFirst Posted
Study publicly available on registry
February 8, 2021
CompletedMay 4, 2022
April 1, 2022
3 months
January 27, 2021
April 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Impact of exercise on expression of Hsp70 in individuals at risk of peripheral arterial disease
This is a clinical trial where 260 individuals were evaluated by a screening test employing the Ankle-Arm Index (ABI). A number of 220 individuals were not within risk value (0.91 to 0.99 mmHg). In the clinical trial, 32 individuals were included. A control group and an experimental group were formed. Aerobic exercise intervention was performed by the experimental group. The level of Hsp70 was evaluated, physical and clinical measurements were applied at the beginning and at the end of the trial.
12 weeks
Study Arms (2)
Control group
NO INTERVENTIONThe control group received written recommendations to exercise three times per week, for a period of 12 weeks but they did not attend the training sessions.
Exercise group
EXPERIMENTALThe experimental group started an exercise program to achieve 65% to 80% of the maximum heart rate by using a pulsometer that measured the heart rate in order to get to the moderate intensity activity goal. The exercise session was 60 minutes long, three times per week, completing 180 minutes per week of moderate intensity exercise, for 12 weeks in total.
Interventions
The experimental group started an exercise program to achieve 65% to 80% of the maximum heart rate by using a pulsometer that measured the heart rate in order to get to the moderate intensity activity goal. The exercise session was 60 minutes long, three times per week, completing 180 minutes per week of moderate intensity exercise, for 12 weeks in total.
Eligibility Criteria
You may qualify if:
- ABI cut point from 0.91 to 0.99
- Age, from 40 to 75 years old
- Both genders
You may not qualify if:
- Unable to perform Bruce's stress test
- Presence of fractures or sprains in the last 3 months
- Diagnosis of diabetes, heart disease, angina pectoris or heart attack
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPAEP
Puebla City, 72410, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Clara Luz Pérez Quiroga, MCs
Universidad Popular Autónoma del Estado de Puebla
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc
Study Record Dates
First Submitted
January 27, 2021
First Posted
February 8, 2021
Study Start
June 3, 2019
Primary Completion
August 30, 2019
Study Completion
August 30, 2019
Last Updated
May 4, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share